ACAD
ACADIA Pharmaceuticals Inc
26.40$
+0.1%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -55,361.7% | -199,663.9% | -1,214.1% | -174.4% | -74.8% | -44.6% | -30.8% | -26.0% | -22.0% | 2.3% | 16.5% | 10.3% | |
| 171.7% | 1,060.7% | 10.5% | 2.2% | 1.3% | 0.8% | 0.7% | 0.7% | 0.4% | 0.8% | 1.7% | 1.1% | |
| 13,365.8% | 65,891.8% | 318.9% | 60.5% | 36.4% | 24.3% | 19.1% | 13.1% | 13.2% | 9.1% | 7.0% | 4.9% | |
| 13,365.8% | 65,486.9% | 316.0% | 60.2% | 37.3% | 24.0% | 29.4% | 12.7% | 12.0% | – | – | – | |
| 7,760.0% | 6,744.3% | 25.4% | -5.1% | -3.7% | 1.1% | 2.5% | -5.1% | 7.3% | 2.5% | 0.4% | -8.4% | |
| 150.0% | 3,509.8% | 54.8% | 0.7% | 1.0% | 0.3% | 1.7% | 0.2% | 0.0% | 5.5% | 0.1% | 0.4% | |
| -72,727.5% | 241,918.0% | -1,511.3% | 74.0% | -31.9% | -48.9% | 43.6% | -14.7% | 14.2% | 4.4% | -3.2% | -28.2% | |
| 0.0% | 0.0% | 0.0% | 0.0% | – | – | – | – | – | – | – | – | |
| 169,875.8% | 23,368.9% | 2,994.0% | 25.0% | 137.0% | 109.7% | 18.3% | 3.8% | – | – | – | – | |
| 169,875.8% | 23,773.8% | 3,080.1% | 25.0% | 137.0% | 109.7% | 18.3% | 3.8% | 1.6% | 3.5% | 0.7% | 4.7% | |
| 41,789.2% | 66,039.3% | 354.8% | -75.4% | 30.2% | 16.2% | 31.1% | -36.9% | -6.3% | 10.2% | 14.0% | -13.2% | |
| -55,511.7% | -203,173.8% | -1,268.9% | -175.1% | -75.8% | -44.9% | -32.5% | -26.2% | -22.0% | -3.2% | 16.4% | 9.8% |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.